Investigating the structure–activity relationship of 1,2,4-triazine G-protein-coupled receptor 84 (GPR84) antagonists

Mahindra, A. et al. (2022) Investigating the structure–activity relationship of 1,2,4-triazine G-protein-coupled receptor 84 (GPR84) antagonists. Journal of Medicinal Chemistry, 65(16), pp. 11270-11290. (doi: 10.1021/acs.jmedchem.2c00804) (PMID:35948061) (PMCID:PMC9421653)

[img] Text
275398.pdf - Published Version
Available under License Creative Commons Attribution.

7MB

Abstract

G-protein-coupled receptor 84 (GPR84) is a proinflammatory orphan G-protein-coupled receptor implicated in several inflammatory and fibrotic diseases. Several agonist and antagonist ligands have been developed that target GPR84; however, a noncompetitive receptor blocker that was progressed to phase II clinical trials failed to demonstrate efficacy. New high-quality antagonists are required to investigate the pathophysiological role of GPR84 and to validate GPR84 as a therapeutic target. We previously reported the discovery of a novel triazine GPR84 competitive antagonist 1. Here, we describe an extensive structure–activity relationship (SAR) of antagonist 1 and also present in silico docking with supporting mutagenesis studies that reveals a potential binding pose for this type of orthosteric antagonist. Lead compound 42 is a potent GPR84 antagonist with a favorable pharmacokinetic (PK) profile suitable for further drug development.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Milligan, Professor Graeme and Jenkins, Mrs Laura and Jamieson, Professor Andrew and Marsango, Dr Sara and Mahindra, Dr Amit
Authors: Mahindra, A., Jenkins, L., Marsango, S., Huggett, M., Huggett, M., Robinson, L., Gillespie, J., Rajamanickam, M., Morrison, A., McElroy, S., Tikhonova, I. G., Milligan, G., and Jamieson, A. G.
College/School:College of Medical Veterinary and Life Sciences > School of Molecular Biosciences
College of Science and Engineering > School of Chemistry
Journal Name:Journal of Medicinal Chemistry
Publisher:American Chemical Society
ISSN:0022-2623
ISSN (Online):1520-4804
Published Online:10 August 2022
Copyright Holders:Copyright © 2022 The Authors
First Published:First published in Journal of Medicinal Chemistry 65(16): 11270-11290
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
305987IPA Responsive Mode BBSRC Resubmission GPR84Graeme MilliganBiotechnology and Biological Sciences Research Council (BBSRC)BB/T000562/1Institute of Molecular, Cell & Systems Biology
308739Development of next generation anti-malarials targeting the essential parasite protein kinase PfCLK3Andrew TobinMedical Research Council (MRC)MR/T030569/1Institute of Molecular, Cell & Systems Biology
303413Glasgow Precision Diagnostics and Therapeutics - Confidence in ConceptAnna DominiczakMedical Research Council (MRC)MC_PC_17160CAMS - Cardiovascular Science